Roche Norway is part of the International F. Hoffmann-La Roche Group that was founded in 1896 in Basel, Switzerland. Roche has grown from a small drug laboratory into one of the world’s leading research-based healthcare companies and is known for many innovative contributions to medicine.
Today Roche is represented in more than 150 countries with over 91 700 employees. Roche has a strong focus on research and development and invests 20% of annual sales back into this purpose. Our work is of high standards in terms of quality, ethics and environmental responsibilities. We are continuously working to improve quality in health and environment for the employees, and follows directives and regulations to ensure product safety and environmental effect. Roche plays an active part in both development and improvement of the environment as a member of several organizations such as the World Environment Center, International Chamber of Commerce and Existing Chemicals Program of OECD.
Today Roche Norway’s business covers both Pharmaceuticals and Diagnostics. In the pharma market Roche is ranked among the top companies while in the Diagnostic sector Roche is the market leader. The combined strengths of our diagnostics and pharmaceutical businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients’ needs. Roche’s products and services address the entire healthcare spectrum, from screening for genetic risk factors to preventing, diagnosing and treating disease and monitoring the treatment response.
Arranged in two operative divisions; pharmaceuticals and diagnostics, our global mission today and tomorrow is to create exceptional added value in healthcare by focusing on our expertise in Diagnostics and Pharmaceuticals.